Angiopoietins and Heart Attacks
Author Information
Author(s): Carlos Iribarren, Bruce H. Phelps, Jeanne A. Darbinian, Edward R. McCluskey, Charles P. Quesenberry, Evangelos Hytopoulos, Joseph H. Vogelman, Norman Orentreich
Primary Institution: Kaiser Permanente Division of Research
Hypothesis
The study aims to examine the association between circulating levels of angiogenic biomarkers and the risk of incident acute myocardial infarction (AMI).
Conclusion
The study found that Ang-2 is a significant biomarker for predicting future heart attacks, independent of traditional risk factors.
Supporting Evidence
- VEGF and Ang-2 levels were significantly higher in AMI cases compared to controls.
- Each increment of Ang-2 was associated with increased odds of AMI.
- The study included a large, diverse population from Kaiser Permanente.
Takeaway
This study shows that higher levels of a protein called Ang-2 in the blood can help predict if someone might have a heart attack in the future.
Methodology
A nested matched case-control study design was used, including 695 AMI cases and 690 matched controls.
Potential Biases
The matched design may limit the ability to estimate incremental discrimination by ROC analysis.
Limitations
The study did not measure other angiogenic factors and had potential issues with protein degradation due to the age of serum samples.
Participant Demographics
Participants were predominantly white, black, Hispanic/Latino, and Asian, with an average age of 62 years.
Statistical Information
P-Value
p<0.0001 for Ang-2
Confidence Interval
1.02 to 1.35 for Ang-2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website